Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GABRP | O00591 | 2/20 | 0.56 |
| ▸ | GABRD | O14764 | 2/20 | 0.56 |
| ▸ | GABRA1 | P14867 | 2/20 | 0.56 |
| ▸ | GABRB1 | P18505 | 2/20 | 0.56 |
| ▸ | GABRG2 | P18507 | 2/20 | 0.56 |
| ▸ | GABRB3 | P28472 | 2/20 | 0.56 |
| ▸ | GABRA5 | P31644 | 2/20 | 0.56 |
| ▸ | GABRA3 | P34903 | 2/20 | 0.56 |
| ▸ | GABRA2 | P47869 | 2/20 | 0.56 |
| ▸ | GABRB2 | P47870 | 2/20 | 0.56 |
| ▸ | GABRA4 | P48169 | 2/20 | 0.56 |
| ▸ | GABRE | P78334 | 2/20 | 0.56 |
| ▸ | GABRA6 | Q16445 | 2/20 | 0.56 |
| ▸ | GABRG1 | Q8N1C3 | 2/20 | 0.56 |
| ▸ | GABRG3 | Q99928 | 2/20 | 0.56 |
| ▸ | GABRQ | Q9UN88 | 2/20 | 0.56 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.56 |
| ▸ | TET2 | Q6N021 | 3/20 | 0.46 |
| ▸ | KDM4A | O75164 | 2/20 | 0.46 |
| ▸ | KDM4C | Q9H3R0 | 2/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL244922 | 1.00 | GABRP (0.56) | GABRPGABRDGABRA1GABRB1GABRG2 | |
| SCHEMBL14360718 | 0.88 | GABRP (0.62) | GABRPGABRDGABRA1GABRB1GABRG2 | |
| SCHEMBL18222768 | 0.84 | LMNA (0.48) | GABRPGABRDGABRA1GABRB1GABRG2 | |
| SCHEMBL22500792 | 0.82 | ALDH1A1 (0.53) | ENPEPLMNANFKB1 | |
| SCHEMBL28714360 | 0.82 | GABRP (0.50) | GABRPGABRDGABRA1GABRB1GABRG2 | |
| SCHEMBL27985207 | 0.82 | FOLH1 (0.41) | GABRPGABRDGABRA1GABRB1GABRG2 | |
| SCHEMBL5081386 | 0.81 | GABRP (0.54) | GABRPGABRDGABRA1GABRB1GABRG2 | |
| SCHEMBL15871660 | 0.81 | GABRP (0.54) | GABRPGABRDGABRA1GABRB1GABRG2 | |
| SCHEMBL8370935 | 0.80 | ALDH1A1 (0.57) | LMNANFKB1 | |
| SCHEMBL7782145 | 0.80 | ALDH1A1 (0.57) | LMNANFKB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10005813-B2 | Methods for the purification of deoxycholic acid | KYTHERA BIOPHARMACEUTICALS, INC. (US) | 2018-06-26 | — | — | US | disclosed |
| US-20170320905-A1 | METHODS FOR THE PURIFICATION OF DEOXYCHOLIC ACID | KYTHERA BIOPHARMACEUTICALS, INC. (US) | 2017-11-09 | — | — | US | disclosed |
| US-9683007-B2 | Methods for the purification of deoxycholic acid | KYTHERA BIOPHARMACEUTICALS, INC. (US) | 2017-06-20 | — | — | US | disclosed |
| US-20150141679-A1 | METHODS FOR THE PURIFICATION OF DEOXYCHOLIC ACID | KYTHERA BIOPHARMACEUTICALS, INC. (US) | 2015-05-21 | — | — | US | disclosed |
| US-20130137884-A1 | METHODS FOR THE PURIFICATION OF DEOXYCHOLIC ACID | Kythera Biopharmaceuticals ,Inc. | 2013-05-30 | — | — | US | disclosed |
| US-8138145-B2 | Hybrid oligomers, their preparation process and pharmaceutical compositions containing them | Centre National de la Recherche Scientifique (SNRS) (FR) | 2012-03-20 | — | — | US | disclosed |
| US-20100298206-A1 | HYBRID OLIGOMERS, THEIR PREPARATION PROCESS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS), I.B.M.C. (FR) | 2010-11-25 | — | — | US | disclosed |
| US-7691807-B2 | Hybrid oligomers, their preparation process and pharmaceutical compositions containing them | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (FR) | 2010-04-06 | — | — | US | disclosed |
| EP-0893422-A1 | Optically active alcohol and process for the production thereof | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 1999-01-27 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150141679-A1 | METHODS FOR THE PURIFICATION OF DEOXYCHOLIC ACID | HSD11B1, HSD17B7, HSD11B2 | GABRP 3292/4885GABRD 708/4885GABRA1 1761/4885 |
| US-20130137884-A1 | METHODS FOR THE PURIFICATION OF DEOXYCHOLIC ACID | HSD11B1, HSD17B7, HSD17B13 | GABRP 3499/4885GABRD 772/4885GABRA1 1857/4885 |
| US-20100298206-A1 | HYBRID OLIGOMERS, THEIR PREPARATION PROCESS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | NOD2, NOD1, COG5 | GABRP 1004/4885GABRD 2727/4885GABRA1 1768/4885 |
| US-10005813-B2 | Methods for the purification of deoxycholic acid | HSD11B1, HSD17B7, HSD17B13 | GABRP 3552/4885GABRD 824/4885GABRA1 1870/4885 |
| US-20170320905-A1 | METHODS FOR THE PURIFICATION OF DEOXYCHOLIC ACID | HSD11B1, HSD17B7, HSD17B13 | GABRP 3552/4885GABRD 824/4885GABRA1 1870/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.